To navigate this market effectively, it is helpful to look at each Non-Alcoholic Steatohepatitis Biomarkers Market segment by the type of biological activity being measured. The market is typically split into apoptosis markers (cell death), oxidative stress markers, and the dominant "fibrosis markers." The fibrosis segment is the most critical, as scarring of the liver is the strongest predictor of long-term mortality.

Another emerging segment is the "imaging-based" biomarker, which uses mechanical waves or magnetic resonance to measure liver stiffness. While more expensive than blood tests, these tools provide a literal "map" of the liver's condition. The future of the market lies in "hybrid" panels that combine the low cost of serum markers with the anatomical detail of imaging.

FAQ

• What is an apoptosis marker? It measures the rate at which liver cells are dying. High levels of these markers (like M30/M65) usually indicate an active NASH infection.

• What is "liver stiffness"? As the liver develops scars (fibrosis), it becomes harder and less flexible. Measuring this stiffness is a key way to determine the stage of the disease.

Related Reports